Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Early hormones shape sex-specific differences in rat glands.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Prolactin may be important for skin growth and immune function.

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Agmatine may help reduce seizures linked to hormone changes in female rats.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

OCT4 helps granulosa cell growth in early-stage follicles, and FSH increases OCT4 through specific pathways.

Neurosteroids show promise for treating epilepsy and more research is needed.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.